The Collaborative Market Data Network -
serving the Public interest of Transparency in Debt Capital Markets
The Collaborative Market Data Network
Serving Transparency in Capital Markets
The Collaborative
Market Data Network

ELI LILLY AND COMPANY [CRP-HLTH-PHARMA] [AA-]

Post Date: 08 May 2026

Eli Lilly and Co has priced a USD denominated multi tranche syndicated Brownie Bond.

For all the deals placed in the market today use the Bond Market or Money Market Viewers.

Issuer Details
Issuer Eli Lilly and Company
LEI FRDRIPF3EKNDJ2CQJL29
Industry Pharmaceuticals
Country United States
Issuer Description Eli Lilly & Company is a pharmaceutical corporation. It develops pharmaceutical products.. Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company products are sold in countries around the world. Eli Lilly products include neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health products.
Generic Credit Rating [Login to see full details]
Moody's Credit Rating [Login to see full details]

 

Trade Details
Security Type Bond
Amount USD [Login to see full details]
Total Amount including taps USD [Login to see full details]
Total Amount Outstanding USD [Login to see full details]
Total Order Book USD [Login to see full details]
Structure Floating Rate
Reoffer [Login to see full details]
Term [Login to see full details]
Trade Date [Login to see full details]
Settlement Date [Login to see full details]
Maturity Date [Login to see full details]
Yield Notes [Login to see full details]

Login to see if this deal qualifies as a Green Bond or Social Bond or other type of ESG Bond.

A Brownie bond is an USD-denominated bond issued by a United-States entity in the USA Domestic Bond market.

Check here for all issuer’s year to date financings.


Continue reading this article?

If you are an Issuer, Dealer (Syndicate/Origination/Trading/Sales) or a Qualified Institutional Investor, a Capital Markets Lawyer or Regulator please try full access.
Register here

Already a subscriber?

Please Sign in